Jacobs Levy Equity Management, Inc Aclaris Therapeutics, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.7 Billion
- Q3 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 915,509 shares of ACRS stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
915,509Holding current value
$2 Million% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding ACRS
# of Institutions
86Shares Held
51.1MCall Options Held
30.6KPut Options Held
1K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$31.1 Million9.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.69MShares$10.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.37MShares$7.35 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.01MShares$6.55 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$6 Million0.11% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $145M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...